- Article
Structure-Based Screening and Molecular Dynamics of Rifampicin Analogues Targeting InhA of Mycobacterium tuberculosis
- Lucas Paul and
- Andrew S. Paluch
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a global health burden, particularly due to multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. Rifampicin, a frontline anti-TB drug that inhibits RNA polymera...

